The scientist’s investigation covers issues in Dendrimer, Nanotechnology, Biochemistry, Biophysics and Drug delivery. His research in the fields of Poly overlaps with other disciplines such as Conjugate. The study incorporates disciplines such as Cancer and Cationic polymerization in addition to Nanotechnology.
In the subject of general Biochemistry, his work in Cytotoxicity, Cytotoxic T cell and Polymerase is often linked to DNA clamp, thereby combining diverse domains of study. James R. Baker interconnects Membrane, Lipid bilayer and In vitro in the investigation of issues within Biophysics. His work carried out in the field of Drug delivery brings together such families of science as Methotrexate, Photodynamic therapy, Drug and Neoplasms diagnosis.
James R. Baker mainly focuses on Dendrimer, Immunology, Nanotechnology, Internal medicine and Biophysics. His Dendrimer study integrates concerns from other disciplines, such as Combinatorial chemistry and Nanoparticle. Specifically, his work in Nanotechnology is concerned with the study of Drug delivery.
His research integrates issues of Hereditary angioedema and Endocrinology in his study of Internal medicine. He has researched Biophysics in several fields, including Membrane, In vitro and Fluorescence. He has included themes like Apoptosis and Cancer research in his Thyroid study.
His main research concerns Immunology, Adjuvant, Immune system, Internal medicine and Hereditary angioedema. His work in Immunology covers topics such as In vitro which are related to areas like Ethanolamine, Lipopolysaccharide binding, Methicillin-resistant Staphylococcus aureus and Antimicrobial. His Ethanolamine study incorporates themes from Dendrimer and Stereochemistry.
The various areas that James R. Baker examines in his Dendrimer study include Base pair and Oligonucleotide. His study in Adjuvant is interdisciplinary in nature, drawing from both Antigen, Immunogenicity, Dehydrogenase and Nasal administration. His Internal medicine research includes elements of Visual analogue scale and Placebo.
His primary scientific interests are in Internal medicine, Hereditary angioedema, Placebo, Immunology and Peanut allergy. The concepts of his Placebo study are interwoven with issues in Angioedema and Kallikrein. His studies in Immunology integrate themes in fields like In vitro and Methicillin-resistant Staphylococcus aureus.
The In vitro study combines topics in areas such as Antimicrobial, Microbiology, Staphylococcus aureus, Antibiotic resistance and Proinflammatory cytokine. In his study, which falls under the umbrella issue of Folate receptor, Stereochemistry is strongly linked to Combinatorial chemistry. His Stereochemistry research is multidisciplinary, relying on both Nanoparticle, Nanomedicine, Biophysics, Photon upconversion and Drug carrier.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers
Jolanta F. Kukowska-Latallo;Anna U. Bielinska;Jennifer Johnson;Ralph Spindler.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer
Jolanta F. Kukowska-Latallo;Kimberly A. Candido;Zhengyi Cao;Shraddha S. Nigavekar.
Cancer Research (2005)
Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor
Antonio Quintana;Ewa Raczka;Lars Piehler;Inhan Lee.
Pharmaceutical Research (2002)
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
Istvan J. Majoros;Andrzej Myc;Thommey Thomas;Chandan B. Mehta.
Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.
Seungpyo Hong;Pascale R. Leroueil;Elizabeth K. Janus;Jennifer L. Peters.
Bioconjugate Chemistry (2006)
Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex ☆
Anil K. Patri;Jolanta F. Kukowska-Latallo;James R. Baker.
Advanced Drug Delivery Reviews (2005)
Dendritic polymer macromolecular carriers for drug delivery
Anil K Patri;István J Majoros;James R Baker.
Current Opinion in Chemical Biology (2002)
Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport.
Seungpyo Hong;Anna U. Bielinska;Almut Mecke;Balazs Keszler.
Bioconjugate Chemistry (2004)
The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform
Seungpyo Hong;Pascale R. Leroueil;István J. Majoros;Bradford G. Orr.
Chemistry & Biology (2007)
Regulation of in vitro Gene Expression Using Antisense Oligonucleotides or Antisense Expression Plasmids Transfected Using Starburst PAMAM Dendrimers
Anna Bielinska;Jolanta F. Kukowska-Latallo;Jennifer Johnson;Donald A. Tomalia.
Nucleic Acids Research (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: